M&A Deal Summary |
|
|---|---|
| Date | 1999-08-31 |
| Target | Implant Innovations |
| Sector | Medical Products |
| Buyer(s) | Biomet |
| Sellers(s) | Advent International |
| Deal Type | Add-on Acquisition |
| Deal Value | 175M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1977 |
| Sector | Medical Products |
| Employees | 7,500 |
| Revenue | 2.7B USD (2013) |
Biomet, Inc. is a designs and manufactures orthopedic medical devices and other products used primarily by surgeons and medical specialists, with distribution in over 70 countries and a product portfolio that encompasses orthopedic joint replacement products, dental reconstructive implants, fixation devices, spinal products and other applications.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Medical Products) | 1 of 2 |
| Type (Add-on Acquisition) | 1 of 2 |
| State (Florida) | 1 of 1 |
| Country (United States) | 1 of 2 |
| Year (1999) | 1 of 1 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-06-18 |
Interpore Spine
Irvine, California, United States nterpore Spine, Ltd. engages in the manufacturing of healthcare products for orthopedic surgeons. |
Buy | $280M |
| Category | Private Equity Firm |
|---|---|
| Founded | 1984 |
| PE ASSETS | 76.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 19 of 222 |
| Sector (Medical Products) | 4 of 5 |
| Type (Add-on Acquisition) | 9 of 82 |
| State (Florida) | 1 of 8 |
| Country (United States) | 10 of 79 |
| Year (1999) | 10 of 14 |
| Size (of disclosed) | 40 of 52 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1999-08-20 |
Lionbridge AI
Waltham, Massachusetts, United States Lionbridge Technologies is a provider of translation, development and testing solutions that enable clients to create, release, manage and maintain their technology applications and Web content globally. Lionbridge enables more than 800 world-leading brands to increase international market share, speed adoption of products and effectively engage their customers in local markets worldwide. Using our innovative cloud technology platforms and our global crowd of more than 100,000 professional cloud workers, we provide translation, online marketing, global content management and application testing solutions that ensure global brand consistency, local relevancy and technical usability across all touch points of the customer lifecycle. Lionbridge Technologies was founded in 1996 and is based in Waltham, Massachusetts. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1999-09-01 |
Alcala Farma SL
Correos, Spain Alcala Farma SL is a manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and OTC products. |
Buy | - |
